Harbin Cultural, Tourism and Sports Industry Expo & 2025 Harbin Marathon Expo Opens 
Universal Digital Announces the Filing of Amended and Restated Financial Statements and MD&A’s 
Victory Square Technologies Reports Q2 2025 Results Highlighted by Revenue Growth, Profitability, and Portfolio Momentum 
American Aires Inc. Announces Business Continuity and Governance Actions Following Special Committee Review 
Zeebu Reaches $10 Billion Settlement Milestone, Proves Programmable Payments Are Production-Ready Pryor Cashman Adds to Its Corporate Practice With New Partners Robert Friedman and Richard Leska
NEW YORK–(BUSINESS WIRE)–Pryor Cashman is pleased to announce that Robert M. Friedman and Richard C….
Iron Bow Technologies Appoints Dan Muse as Chief Financial Officer
HERNDON, Va.–(BUSINESS WIRE)–#IT–Iron Bow Technologies, the leading technology solutions provider to government, commercial, and healthcare…
79% of CX Leaders Plan to Increase Investment in Contact Center AI and Automation
Global Talkdesk Research report shows value of AI remains uncontested, but barriers persist in fully…
Home Sales Are Getting Canceled at the Highest Rate Since the Start of the Pandemic
Some homebuyers are backing out of deals as a slowing housing market gives them more…
Novum Orthopedic Partners Expands Its Physician Practice Management Platform in Dallas-Fort Worth with Investment in North Texas Orthopedics & Spine Center
The new partnership represents a continuum of Novum’s strategy to build a network of like-minded,…
Kingston Digital Releases Type-A Addition to DataTraveler Max USB 3.2 Gen 2 Series
Advanced USB 3.2 Gen 2 Type-A USB High Speed, High Capacity FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–#KingstonFURY–Kingston…
Cadence to Acquire Future Facilities, A Pioneer in Data Center Digital Twins
Engineering simulation-driven, physics-based 3D digital twins for sustainable data center design and operations SAN JOSE,…
CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy Based on Leronlimab
$5 Million Grant Awarded to OHSU for Preclinical Research of One-time Injection of Gene Therapy…
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI)…
Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
IRVINE, Calif., July 11, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Arcutis Biotherapeutics Announces Health Canada Accepts for Review the New Drug Submission for Roflumilast Cream for Adults and Adolescents with Plaque Psoriasis
Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical…
Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
Study results for the sublingual administration of AQST-109 epinephrine oral film after consuming a peanut…
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
Molecular Diagnostic Test for Early Detection of Lyme Disease LEXINGTON, Mass., July 11, 2022 (GLOBE…
Kala Pharmaceuticals Completes Sale of EYSUVIS® and INVELTYS® to Alcon Inc
ARLINGTON, Mass, July 11, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical…
Apexigen to Participate in the Brookline Capital Markets Newport Symposium
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (“Apexigen”), a clinical-stage company…
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
BOSTON, July 11, 2022 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
Athenex Announces Entry into Agreement to Sell its China API Business to TiHe Capital (Bejing) Co., Ltd.
Expected sale proceeds of approximately $19.0 million Company continues to monetize non-core assets to extend…
US FDA Grants Spectral Medical Breakthrough Device Designation for Toraymyxin™ (“PMX”) for the Treatment of Endotoxemic Septic Shock
Breakthrough designation expected to help accelerate regulatory review TORONTO, July 11, 2022 (GLOBE NEWSWIRE) —…
EyePoint Pharmaceuticals to Host Investor Day on July 18, 2022
– Guest speakers Carl Regillo, M.D., FACS, Professor of Ophthalmology, Thomas Jefferson University and Charles…
Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA
–SPA supports protocol for Phase 3 Clinical Trial of Oral Sulopenem for the treatment of…